Stockscreener 앱 받기
2.92
1.35%
-0.04
전일 마감가:
$2.96
열려 있는:
$2.94
하루 거래량:
287.57K
Relative Volume:
0.22
시가총액:
$109.17M
수익:
-
순이익/손실:
$-9.32M
주가수익비율:
-0.2297
EPS:
-12.7107
순현금흐름:
$-7.30M
1주 성능:
+4.66%
1개월 성능:
+21.16%
6개월 성능:
+79.14%
1년 성능:
+46.00%
1일 변동 폭
$2.91
$3.03
1주일 범위
$2.76
$3.09
52주 변동 폭
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
명칭
Tharimmune Inc
전화
302-743-2995
주소
1200 ROUTE 22 EAST, BRIDGEWATER
THAR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
2.92 | 110.66M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tharimmune Inc 주식(THAR)의 최신 뉴스
Aug Catalysts: Is Tharimmune Inc exposed to currency risksWeekly Trade Report & Daily Profit Focused Screening - baoquankhu1.vn
Tharimmune Addresses Nasdaq Board Independence Compliance Notice - TipRanks
Tharimmune Received Notice of Noncompliance - TradingView — Track All Markets
Market Outlook: What is BCSFs 5 year growth outlookJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
Quarterly Risk: Will Tharimmune Inc stock outperform Nasdaq index2025 Bull vs Bear & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Tharimmune (NASDAQ:THAR) Stock Price Down 4.1% – Here’s What Happened - Defense World
Tharimmune (NASDAQ:THAR) Stock Price Down 4.1%Here's What Happened - MarketBeat
Tharimmune files for mixed shelf of up to $2.0 blnSEC filing - marketscreener.com
Is Tharimmune Inc. stock a safe buy before earningsQuarterly Profit Report & Verified Momentum Stock Alerts - Улправда
What analyst consensus says on Tharimmune Inc. stockTrade Entry Report & Safe Entry Momentum Stock Tips - Улправда
Published on: 2026-01-09 04:07:29 - Улправда
Is Tharimmune Inc. stock attractive for income investorsJuly 2025 Earnings & AI Optimized Trading Strategy Guides - Улправда
Will Tharimmune Inc. stock reach Wall Street targetsJuly 2025 Update & Reliable Entry Point Trade Alerts - Улправда
Breakout Zone: Is Tharimmune Inc stock attractive for income investorsRecession Risk & Safe Capital Growth Trade Ideas - moha.gov.vn
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors - Burlington Free Press
What technical signals suggest for Tharimmune Inc. stockJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - Улправда
Can Tharimmune Inc. stock hit record highs again2025 Stock Rankings & AI Forecast Swing Trade Picks - Улправда
Will Tharimmune Inc. stock benefit from AI adoptionWeekly Trend Report & High Conviction Trade Alerts - DonanımHaber
THAR SEC FilingsTharimmune Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tharimmune (NASDAQ:THAR) Stock Price Down 5.9%What's Next? - MarketBeat
Is Tharimmune Inc. stock attractive for ETFs2025 Fundamental Recap & Weekly Return Optimization Alerts - DonanımHaber
How Tharimmune Inc. stock performs in rising dollar environmentJuly 2025 Opening Moves & Community Verified Trade Alerts - DonanımHaber
Sentiment Recap: Can Tharimmune Inc. stock weather global recession2025 AllTime Highs & Capital Protection Trade Alerts - Улправда
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network - marketscreener.com
DTCC move to tokenize $30T in Treasuries—and why one biotech cares - Stock Titan
DTCC partners with Digital Asset to tokenize US Treasury securities - Investing.com
Tharimmune (THAR) outlines 176,934,358-share PIPE resale and Canton Coin strategy - Stock Titan
Tharimmune (NASDAQ: THAR) seeks approval for new directors, warrants and 7M-share equity plan boost - Stock Titan
Tharimmune appoints Jacob Asbury as new CFO - MSN
Tharimmune Appoints Jacob Asbury as Chief Financial Officer - citybiz
Tharimmune Appoints Jacob Asbury as New CFO - TipRanks
Tharimmune, Inc. Appoints New Chief Financial Officer - TradingView — Track All Markets
Tharimmune (NASDAQ: THAR) names Jacob Asbury CFO with new employment agreement - Stock Titan
Tharimmune appoints Jacob Asbury as chief financial officer - Investing.com
Tharimmune (NASDAQ: THAR) appoints ex‑Clear Street CFO Asbury to guide Canton Coin treasury build‑out - Stock Titan
Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy - FinancialContent
Why Tharimmune Inc. stock remains a top recommendation2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - Newser
How buybacks impact Tharimmune Inc. stock value2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
Tharimmune (NASDAQ: THAR) details agent change in $64,910,161 stock plan - Stock Titan
How Tharimmune Inc. stock reacts to Fed rate cutsPortfolio Gains Report & Consistent Income Trade Ideas - Newser
Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback - The Holland Sentinel
Will Tharimmune Inc. stock benefit from infrastructure spendingInsider Buying & Technical Entry and Exit Tips - Newser
Is Tharimmune Inc. stock attractive for growth ETFsEarnings Recap Summary & High Return Stock Watch Alerts - Newser
Tharimmune (THAR) Stock Analysis Report | Financials & Insights - Benzinga
Can Tharimmune Inc. stock weather global recessionMarket Trend Report & AI Enhanced Trade Execution Alerts - BỘ NỘI VỤ
Reviewing Tharimmune (NASDAQ:THAR) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
‘We refused to do an ICO’: The truth behind Canton’s tokenomics - TradingView — Track All Markets
Tharimmune Raises $545 Million in Private Placement to Acquire Canton Coin and Expand Blockchain Adoption - Global Legal Chronicle
What drives Tharimmune Inc stock priceSmall Cap Stock Opportunities & Build Capital Safely - earlytimes.in
Tharimmune Shares Jump After FDA Signals Support for TH104 Modeling Plan - MSN
Crypto Company Creates Bizarre Drug - Futurism
Tharimmune Inc (THAR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):